Skip to content
8-K/A

Material Event

Esperion Therapeutics, Inc. ESPR

0001628280-26-044260

← back to feed
Filed
Jun 18, 2026 4:04 PM ET
Period of report
—
Amendment. Amends a previously filed report.

On SEC.gov

Primary document ↗ Inline XBRL ↗ Filing index ↗

Financials in this filing

Structured financials aren't available for this filing — it may be an event-driven form (8-K/6-K), pre-date XBRL (~2009), or report only narrative content. Use the SEC.gov links above to read it.